Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine dose comparison with stroke volume variability monitoring in precision hepatectomy
ChiCTR2100050773Phase 4Completed
- Sponsor
- Hunan Provincial People's Hospital
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine in hepatic disease (3 arms), sponsored by Hunan Provincial People's Hospital. Primary endpoints: Tumor necrosis factor alpha, Interleukin-6 and 3 more. Started Dec 2018; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
hepatic disease
Beyond the preview
Go deeper on ChiCTR2100050773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050773.